Injective vs Maverick Protocol — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,76T 24h volume), while Maverick Protocol trades at Rp169.19 (market cap Rp198,11M, Rp30,65M 24h volume). The key difference: Injective is far larger — about 46893.1× Maverick Protocol's market cap, and Maverick Protocol's supply is capped (1,2B / 2B MAV (59%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Maverick Protocol for 25 Days on average.
| INJ | MAV | |
|---|---|---|
Market Cap | Rp9,29T | Rp198,11M |
Volume (24h) | Rp1,76T | Rp30,65M |
Circulating Supply | 100M INJ | 1,2B / 2B MAV (59%) |
Typical Hold Time | 36 Days | 25 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Maverick Protocol (MAV) is trading at Rp171.55 with a market cap of Rp199.36M, showing bearish technical signals as moving averages indicate strong selling pressure while oscillators remain neutral. The token trades near its pivot point of Rp171 with support at Rp167 and resistance at Rp175. With 59% of the 2M max supply in circulation and average hold time of 25 days, the asset shows moderate distribution but limited recent fundamental developments in the protocol ecosystem.
Overall outlook remains cautious with bearish technical dominance outweighing neutral oscillators. Key opportunity lies in potential bounce from support levels, while major risks include low liquidity depth and the token's proximity to critical support zones that could trigger further selling if breached.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Maverick Protocol is a DeFi infrastructure provider focused on enhancing industry efficiency, powered by Maverick AMM. Maverick is backed by Founders Fund, Pantera Capital, Coinbase Ventures, Binance Labs, Circle Ventures, Gemini, etc. Maverick is eliminating inefficiency from DeFi by helping users put their liquidity where it can do the most work, hence providing smoother and more efficient transactions. This addresses some of the liquidity challenges that have historically troubled the DeFi space.
Read more on MAV →